Opportunities for Green Transformation of Global Pharmaceutical Supply Chain in 2025 - Organic Salts Products Contribute to Sustainable Pharmaceutical Innovation
Under the background of the global pharmaceutical industry accelerating the green and low-carbon transformation, Shandong Unite New Material Co., Ltd., with more than 20 years of deep cultivation experience in fine chemicals, is actively responding to industry hotspots and promoting the application upgrade of organic salts products in the pharmaceutical field. In 2025, with the revision of the EU REACH regulation (more strict environmental protection requirements for exports such as citric acid will be implemented from 2026), the intensification of Sino-US trade friction to increase the demand for supply chain localization, and the urgent pursuit of pharmaceutical enterprises for sustainable raw materials, Unite's green organic salts series products are facing new development opportunities.
Key Hotspots and Unite's Responses
- Supply Chain Resilience and Green Manufacturing: In 2025, the global pharmaceutical supply chain is facing multiple challenges such as geopolitical risks, API intermediate shortages, and environmental protection pressures. As the world's largest fine chemical production country, China is accelerating the transformation from "raw material export" to "green innovation". Unite's factory has achieved 70% green energy use, adopted Siemens DCS intelligent control system, and reduced energy consumption by more than 30%, helping customers cope with the new EU REACH regulations and the global carbon neutrality goal.
- Surge in Demand for Pharmaceutical Excipients and Preservatives: With the acceleration of chronic disease drug research and development, pharmaceutical enterprises' demand for high-purity organic salts in line with pharmacopoeia standards continues to grow. Unite's core products - propionic acid, butyric acid, sorbic acid, sodium benzoate, citric acid, etc. - are widely used in pharmaceutical preservatives, pH regulators, and excipients. Microbial indicators strictly meet pharmaceutical standards and can provide reliable raw material support for antibiotics, injections, and oral preparations.
- Market Trend Insights: According to 2025 industry reports, the global pharmaceutical intermediate market size is expected to reach more than $35 billion, and as a key basic raw material, organic salts have a compound annual growth rate of more than 7% in demand. Unite has established long-term cooperation with many international pharmaceutical enterprises, provided customized ODM/OEM services, and is equipped with a full-process traceable logistics system to ensure supply chain stability.
Highlights of Unite's Products
- Propionic Acid and Its Salts: Applied in food/feed preservation and pharmaceutical pH regulation, with continuous growth in market demand.
- Sorbic Acid and Its Potassium Salt: A natural source preservative, widely used in medicines and cosmetics, with prominent green attributes.
- Sodium Benzoate: The preferred preservative for beverages and medicines, leading in the Southeast Asian market globally.
- Citric Acid: A core raw material for pharmaceutical excipients, Unite has laid out REACH compliance solutions in advance.
Unite will continue to adhere to the concept of "green innovation, sustainable service", increase R&D investment, and work with global pharmaceutical partners to build a resilient and environmentally friendly supply chain system. Welcome industry colleagues to contact us and jointly explore new opportunities in green pharmaceuticals!"
